Researchers say cost-effective treatment that cuts heart disease and stroke risk is linked to better health in older age
Vous n'êtes pas connecté
Patients taking semaglutide injections are less likely to die of any cause, including from cardiovascular disease and infections like COVID-19, an international study led by researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, finds.
Researchers say cost-effective treatment that cuts heart disease and stroke risk is linked to better health in older age
Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought,...
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
A new study from Mass General Brigham researchers provides evidence that large language models (LLMs), used for generative artificial intelligence...
The US Presidential Election 2024 brings two distinct healthcare visions from Kamala Harris and Donald Trump, reflecting broader ideological...
Study reviews cardiovascular side effects linked to antiviral therapies for COVID-19, highlighting the need for careful consideration when prescribing...
A recent study led by researchers at Imperial College London and Imperial College Healthcare NHS Trust suggests that some patients with chest pain due...
A recent study led by researchers at Imperial College London and Imperial College Healthcare NHS Trust suggests that some patients with chest pain due...
Child deaths from infections see ‘remarkable’ decline but AMR fatalities of over-70s likely to rise by 146%, study finds